| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/28/2023 | 681.25% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
| 09/13/2023 | 525% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 08/15/2023 | 446.87% | Morgan Stanley | $11 → $7 | Maintains | Overweight |
| 08/11/2023 | 525% | HC Wainwright & Co. | $11 → $8 | Reiterates | Buy → Buy |
| 03/15/2023 | 681.25% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 01/24/2023 | 759.37% | Morgan Stanley | $15 → $11 | Maintains | Overweight |
| 11/21/2022 | 681.25% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
| 11/30/2021 | 1540.62% | Morgan Stanley | → $21 | Initiates Coverage On | → Overweight |
| 11/30/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 11/30/2021 | 1462.5% | Jefferies | → $20 | Initiates Coverage On | → Buy |
What is the target price for IO Biotech (IOBT)?
There is no price target for IO Biotech
What is the most recent analyst rating for IO Biotech (IOBT)?
There is no analyst for IO Biotech
When is the next analyst rating going to be posted or updated for IO Biotech (IOBT)?
There is no next analyst rating for IO Biotech
Is the Analyst Rating IO Biotech (IOBT) correct?
There is no next analyst rating for IO Biotech